Blueclinical Investigacao E Desenvolvimento Em Saude Lda. — Clinical Trial Site

86 Registered trials

2 Currently recruiting

Organisation

Blueclinical Investigacao E Desenvolvimento Em Saude Lda.

Location

Porto, Portugal

Identifier

ORG-100011139

Address

Rua De Sarmento De Beires 153 0 Floor 3rd Floor, 4250-449, Portugal

Departments

Allergy and Clinical Inmunology
BlueClinical Phase I
Med
Medical Management

Clinical trials at this site (86)

Search interface

Comparative Bioavailability of Lenvatinib 10 mg Capsules in Healthy Subjects Ended

2022-501327-25-00 Advanced or recurrent endometrial carcinoma in adults w 2 2023-05-13
Bioequivalence of Testosterone Transdermal Gel in Healthy Female Subjects Ended

2022-501514-56-00 Male hypogonadism 2 2023-05-02
A Randomized, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Relative Bioavailability of LY03010 versus Xeplion® after Intram… Ended

2022-502179-48-00 Schizophrenia 2 2023-02-23
Bioequivalence of Oxazepam 50 mg Orodispersible Tablets Versus Seresta® 50 mg Tablets in Healthy Subjects. Ended

2022-501135-16-00 No medical condition is being investigated. This is a c 2 2022-12-26
A Phase I, Open-Label Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytis… Ended

2022-500921-34-00 Nicotine addiction 3 2022-12-13
A study to investigate pharmacokinetics and safety of rupatadine (10 mg) and its active metabolites in participants with hepatic impairment … Ended

2022-500774-34-00 Urticaria 3 2022-11-08
A study to investigate pharmacokinetics and safety of rupatadine (10 mg) and its active metabolites in participants with renal impairment co… Ended

2022-500775-31-00 Allergic rhinitis 3 2022-11-08
Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Versus Seresta® 10 mg Tablets in Healthy Subjects Ended

2022-501134-35-00 No medical condition is being investigated. This is a c 2 2022-10-26
A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisin… Ended

2022-500954-40-00 Nicotine addiction 3 2022-10-17
Comparative Bioavailability of Nilotinib 200 mg Hard Capsules in Healthy Subjects. Ended

2022-501325-20-00 Primary Philadelphia-chromosome positive leukemia cells 2 2022-10-06
Bioequivalence of Eltrombopag 25 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions. Ended

2023-504468-41-00 No medical condition 2
Comparative Bioavailability of Diclofenac 2.32% Gel in Healthy Adult Subjects Ended

2023-507428-21-00 No medical condition. 2
Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fed Conditions Ended

2024-512912-23-00 No medical condition 2
Comparative Bioavailability of Teriflunomide 14 mg Film-Coated Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, … Ended

2024-516401-23-00 No medical condition. 2